1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Janus Kinase (JAK) Inhibitors Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Ruxolitinib 1.2.3 Tofacitinib 1.2.4 Oclacitinib 1.2.5 Baricitinib 1.2.6 Peficitinib 1.3 Market by Application 1.3.1 Global Janus Kinase (JAK) Inhibitors Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Autoimmune Disorders 1.3.3 Oncology 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Janus Kinase (JAK) Inhibitors Market Perspective (2016-2027) 2.2 Janus Kinase (JAK) Inhibitors Growth Trends by Regions 2.2.1 Janus Kinase (JAK) Inhibitors Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Janus Kinase (JAK) Inhibitors Historic Market Share by Regions (2016-2021) 2.2.3 Janus Kinase (JAK) Inhibitors Forecasted Market Size by Regions (2022-2027) 2.3 Janus Kinase (JAK) Inhibitors Industry Dynamic 2.3.1 Janus Kinase (JAK) Inhibitors Market Trends 2.3.2 Janus Kinase (JAK) Inhibitors Market Drivers 2.3.3 Janus Kinase (JAK) Inhibitors Market Challenges 2.3.4 Janus Kinase (JAK) Inhibitors Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Janus Kinase (JAK) Inhibitors Players by Revenue 3.1.1 Global Top Janus Kinase (JAK) Inhibitors Players by Revenue (2016-2021) 3.1.2 Global Janus Kinase (JAK) Inhibitors Revenue Market Share by Players (2016-2021) 3.2 Global Janus Kinase (JAK) Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Janus Kinase (JAK) Inhibitors Revenue 3.4 Global Janus Kinase (JAK) Inhibitors Market Concentration Ratio 3.4.1 Global Janus Kinase (JAK) Inhibitors Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Janus Kinase (JAK) Inhibitors Revenue in 2020 3.5 Janus Kinase (JAK) Inhibitors Key Players Head office and Area Served 3.6 Key Players Janus Kinase (JAK) Inhibitors Product Solution and Service 3.7 Date of Enter into Janus Kinase (JAK) Inhibitors Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Janus Kinase (JAK) Inhibitors Breakdown Data by Type 4.1 Global Janus Kinase (JAK) Inhibitors Historic Market Size by Type (2016-2021) 4.2 Global Janus Kinase (JAK) Inhibitors Forecasted Market Size by Type (2022-2027) 5 Janus Kinase (JAK) Inhibitors Breakdown Data by Application 5.1 Global Janus Kinase (JAK) Inhibitors Historic Market Size by Application (2016-2021) 5.2 Global Janus Kinase (JAK) Inhibitors Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Janus Kinase (JAK) Inhibitors Market Size (2016-2027) 6.2 North America Janus Kinase (JAK) Inhibitors Market Size by Type 6.2.1 North America Janus Kinase (JAK) Inhibitors Market Size by Type (2016-2021) 6.2.2 North America Janus Kinase (JAK) Inhibitors Market Size by Type (2022-2027) 6.2.3 North America Janus Kinase (JAK) Inhibitors Market Size by Type (2016-2027) 6.3 North America Janus Kinase (JAK) Inhibitors Market Size by Application 6.3.1 North America Janus Kinase (JAK) Inhibitors Market Size by Application (2016-2021) 6.3.2 North America Janus Kinase (JAK) Inhibitors Market Size by Application (2022-2027) 6.3.3 North America Janus Kinase (JAK) Inhibitors Market Size by Application (2016-2027) 6.4 North America Janus Kinase (JAK) Inhibitors Market Size by Country 6.4.1 North America Janus Kinase (JAK) Inhibitors Market Size by Country (2016-2021) 6.4.2 North America Janus Kinase (JAK) Inhibitors Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Janus Kinase (JAK) Inhibitors Market Size (2016-2027) 7.2 Europe Janus Kinase (JAK) Inhibitors Market Size by Type 7.2.1 Europe Janus Kinase (JAK) Inhibitors Market Size by Type (2016-2021) 7.2.2 Europe Janus Kinase (JAK) Inhibitors Market Size by Type (2022-2027) 7.2.3 Europe Janus Kinase (JAK) Inhibitors Market Size by Type (2016-2027) 7.3 Europe Janus Kinase (JAK) Inhibitors Market Size by Application 7.3.1 Europe Janus Kinase (JAK) Inhibitors Market Size by Application (2016-2021) 7.3.2 Europe Janus Kinase (JAK) Inhibitors Market Size by Application (2022-2027) 7.3.3 Europe Janus Kinase (JAK) Inhibitors Market Size by Application (2016-2027) 7.4 Europe Janus Kinase (JAK) Inhibitors Market Size by Country 7.4.1 Europe Janus Kinase (JAK) Inhibitors Market Size by Country (2016-2021) 7.4.2 Europe Janus Kinase (JAK) Inhibitors Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Janus Kinase (JAK) Inhibitors Market Size (2016-2027) 8.2 Asia-Pacific Janus Kinase (JAK) Inhibitors Market Size by Type 8.2.1 Asia-Pacific Janus Kinase (JAK) Inhibitors Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Janus Kinase (JAK) Inhibitors Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Janus Kinase (JAK) Inhibitors Market Size by Type (2016-2027) 8.3 Asia-Pacific Janus Kinase (JAK) Inhibitors Market Size by Application 8.3.1 Asia-Pacific Janus Kinase (JAK) Inhibitors Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Janus Kinase (JAK) Inhibitors Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Janus Kinase (JAK) Inhibitors Market Size by Application (2016-2027) 8.4 Asia-Pacific Janus Kinase (JAK) Inhibitors Market Size by Region 8.4.1 Asia-Pacific Janus Kinase (JAK) Inhibitors Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Janus Kinase (JAK) Inhibitors Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Janus Kinase (JAK) Inhibitors Market Size (2016-2027) 9.2 Latin America Janus Kinase (JAK) Inhibitors Market Size by Type 9.2.1 Latin America Janus Kinase (JAK) Inhibitors Market Size by Type (2016-2021) 9.2.2 Latin America Janus Kinase (JAK) Inhibitors Market Size by Type (2022-2027) 9.2.3 Latin America Janus Kinase (JAK) Inhibitors Market Size by Type (2016-2027) 9.3 Latin America Janus Kinase (JAK) Inhibitors Market Size by Application 9.3.1 Latin America Janus Kinase (JAK) Inhibitors Market Size by Application (2016-2021) 9.3.2 Latin America Janus Kinase (JAK) Inhibitors Market Size by Application (2022-2027) 9.3.3 Latin America Janus Kinase (JAK) Inhibitors Market Size by Application (2016-2027) 9.4 Latin America Janus Kinase (JAK) Inhibitors Market Size by Country 9.4.1 Latin America Janus Kinase (JAK) Inhibitors Market Size by Country (2016-2021) 9.4.2 Latin America Janus Kinase (JAK) Inhibitors Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Janus Kinase (JAK) Inhibitors Market Size (2016-2027) 10.2 Middle East & Africa Janus Kinase (JAK) Inhibitors Market Size by Type 10.2.1 Middle East & Africa Janus Kinase (JAK) Inhibitors Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Janus Kinase (JAK) Inhibitors Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Janus Kinase (JAK) Inhibitors Market Size by Type (2016-2027) 10.3 Middle East & Africa Janus Kinase (JAK) Inhibitors Market Size by Application 10.3.1 Middle East & Africa Janus Kinase (JAK) Inhibitors Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Janus Kinase (JAK) Inhibitors Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Janus Kinase (JAK) Inhibitors Market Size by Application (2016-2027) 10.4 Middle East & Africa Janus Kinase (JAK) Inhibitors Market Size by Country 10.4.1 Middle East & Africa Janus Kinase (JAK) Inhibitors Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Janus Kinase (JAK) Inhibitors Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Astellas Pharma, Inc. 11.1.1 Astellas Pharma, Inc. Company Details 11.1.2 Astellas Pharma, Inc. Business Overview 11.1.3 Astellas Pharma, Inc. Janus Kinase (JAK) Inhibitors Introduction 11.1.4 Astellas Pharma, Inc. Revenue in Janus Kinase (JAK) Inhibitors Business (2016-2021) 11.1.5 Astellas Pharma, Inc. Recent Development 11.2 Eli Lilly and Co. 11.2.1 Eli Lilly and Co. Company Details 11.2.2 Eli Lilly and Co. Business Overview 11.2.3 Eli Lilly and Co. Janus Kinase (JAK) Inhibitors Introduction 11.2.4 Eli Lilly and Co. Revenue in Janus Kinase (JAK) Inhibitors Business (2016-2021) 11.2.5 Eli Lilly and Co. Recent Development 11.3 Incyte Corp. 11.3.1 Incyte Corp. Company Details 11.3.2 Incyte Corp. Business Overview 11.3.3 Incyte Corp. Janus Kinase (JAK) Inhibitors Introduction 11.3.4 Incyte Corp. Revenue in Janus Kinase (JAK) Inhibitors Business (2016-2021) 11.3.5 Incyte Corp. Recent Development 11.4 Novartis AG 11.4.1 Novartis AG Company Details 11.4.2 Novartis AG Business Overview 11.4.3 Novartis AG Janus Kinase (JAK) Inhibitors Introduction 11.4.4 Novartis AG Revenue in Janus Kinase (JAK) Inhibitors Business (2016-2021) 11.4.5 Novartis AG Recent Development 11.5 Pfizer Inc. 11.5.1 Pfizer Inc. Company Details 11.5.2 Pfizer Inc. Business Overview 11.5.3 Pfizer Inc. Janus Kinase (JAK) Inhibitors Introduction 11.5.4 Pfizer Inc. Revenue in Janus Kinase (JAK) Inhibitors Business (2016-2021) 11.5.5 Pfizer Inc. Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Janus Kinase (JAK) Inhibitors Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Ruxolitinib Table 3. Key Players of Tofacitinib Table 4. Key Players of Oclacitinib Table 5. Key Players of Baricitinib Table 6. Key Players of Peficitinib Table 7. Global Janus Kinase (JAK) Inhibitors Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Janus Kinase (JAK) Inhibitors Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 9. Global Janus Kinase (JAK) Inhibitors Market Size by Regions (2016-2021) & (US$ Million) Table 10. Global Janus Kinase (JAK) Inhibitors Market Share by Regions (2016-2021) Table 11. Global Janus Kinase (JAK) Inhibitors Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 12. Global Janus Kinase (JAK) Inhibitors Market Share by Regions (2022-2027) Table 13. Janus Kinase (JAK) Inhibitors Market Trends Table 14. Janus Kinase (JAK) Inhibitors Market Drivers Table 15. Janus Kinase (JAK) Inhibitors Market Challenges Table 16. Janus Kinase (JAK) Inhibitors Market Restraints Table 17. Global Janus Kinase (JAK) Inhibitors Revenue by Players (2016-2021) & (US$ Million) Table 18. Global Janus Kinase (JAK) Inhibitors Market Share by Players (2016-2021) Table 19. Global Top Janus Kinase (JAK) Inhibitors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Janus Kinase (JAK) Inhibitors as of 2020) Table 20. Ranking of Global Top Janus Kinase (JAK) Inhibitors Companies by Revenue (US$ Million) in 2020 Table 21. Global 5 Largest Players Market Share by Janus Kinase (JAK) Inhibitors Revenue (CR5 and HHI) & (2016-2021) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Janus Kinase (JAK) Inhibitors Product Solution and Service Table 24. Date of Enter into Janus Kinase (JAK) Inhibitors Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Janus Kinase (JAK) Inhibitors Market Size by Type (2016-2021) (US$ Million) Table 27. Global Janus Kinase (JAK) Inhibitors Revenue Market Share by Type (2016-2021) Table 28. Global Janus Kinase (JAK) Inhibitors Forecasted Market Size by Type (2022-2027) (US$ Million) Table 29. Global Janus Kinase (JAK) Inhibitors Revenue Market Share by Type (2022-2027) & (US$ Million) Table 30. Global Janus Kinase (JAK) Inhibitors Market Size Share by Application (2016-2021) & (US$ Million) Table 31. Global Janus Kinase (JAK) Inhibitors Revenue Market Share by Application (2016-2021) Table 32. Global Janus Kinase (JAK) Inhibitors Forecasted Market Size by Application (2022-2027) (US$ Million) Table 33. Global Janus Kinase (JAK) Inhibitors Revenue Market Share by Application (2022-2027) & (US$ Million) Table 34. North America Janus Kinase (JAK) Inhibitors Market Size by Type (2016-2021) (US$ Million) Table 35. North America Janus Kinase (JAK) Inhibitors Market Size by Type (2022-2027) & (US$ Million) Table 36. North America Janus Kinase (JAK) Inhibitors Market Size by Application (2016-2021) (US$ Million) Table 37. North America Janus Kinase (JAK) Inhibitors Market Size by Application (2022-2027) & (US$ Million) Table 38. North America Janus Kinase (JAK) Inhibitors Market Size by Country (2016-2021) & (US$ Million) Table 39. North America Janus Kinase (JAK) Inhibitors Market Size by Country (2022-2027) & (US$ Million) Table 40. Europe Janus Kinase (JAK) Inhibitors Market Size by Type (2016-2021) (US$ Million) Table 41. Europe Janus Kinase (JAK) Inhibitors Market Size by Type (2022-2027) & (US$ Million) Table 42. Europe Janus Kinase (JAK) Inhibitors Market Size by Application (2016-2021) (US$ Million) Table 43. Europe Janus Kinase (JAK) Inhibitors Market Size by Application (2022-2027) & (US$ Million) Table 44. Europe Janus Kinase (JAK) Inhibitors Market Size by Country (2016-2021) & (US$ Million) Table 45. Europe Janus Kinase (JAK) Inhibitors Market Size by Country (2022-2027) & (US$ Million) Table 46. Asia-Pacific Janus Kinase (JAK) Inhibitors Market Size by Type (2016-2021) (US$ Million) Table 47. Asia-Pacific Janus Kinase (JAK) Inhibitors Market Size by Type (2022-2027) & (US$ Million) Table 48. Asia-Pacific Janus Kinase (JAK) Inhibitors Market Size by Application (2016-2021) (US$ Million) Table 49. Asia-Pacific Janus Kinase (JAK) Inhibitors Market Size by Application (2022-2027) & (US$ Million) Table 50. Asia-Pacific Janus Kinase (JAK) Inhibitors Market Size by Region (2016-2021) & (US$ Million) Table 51. Asia-Pacific Janus Kinase (JAK) Inhibitors Market Size by Region (2022-2027) & (US$ Million) Table 52. Latin America Janus Kinase (JAK) Inhibitors Market Size by Type (2016-2021) (US$ Million) Table 53. Latin America Janus Kinase (JAK) Inhibitors Market Size by Type (2022-2027) & (US$ Million) Table 54. Latin America Janus Kinase (JAK) Inhibitors Market Size by Application (2016-2021) (US$ Million) Table 55. Latin America Janus Kinase (JAK) Inhibitors Market Size by Application (2022-2027) & (US$ Million) Table 56. Latin America Janus Kinase (JAK) Inhibitors Market Size by Country (2016-2021) & (US$ Million) Table 57. Latin America Janus Kinase (JAK) Inhibitors Market Size by Country (2022-2027) & (US$ Million) Table 58. Middle East & Africa Janus Kinase (JAK) Inhibitors Market Size by Type (2016-2021) (US$ Million) Table 59. Middle East & Africa Janus Kinase (JAK) Inhibitors Market Size by Type (2022-2027) & (US$ Million) Table 60. Middle East & Africa Janus Kinase (JAK) Inhibitors Market Size by Application (2016-2021) (US$ Million) Table 61. Middle East & Africa Janus Kinase (JAK) Inhibitors Market Size by Application (2022-2027) & (US$ Million) Table 62. Middle East & Africa Janus Kinase (JAK) Inhibitors Market Size by Country (2016-2021) & (US$ Million) Table 63. Middle East & Africa Janus Kinase (JAK) Inhibitors Market Size by Country (2022-2027) & (US$ Million) Table 64. Astellas Pharma, Inc. Company Details Table 65. Astellas Pharma, Inc. Business Overview Table 66. Astellas Pharma, Inc. Janus Kinase (JAK) Inhibitors Product Table 67. Astellas Pharma, Inc. Revenue in Janus Kinase (JAK) Inhibitors Business (2016-2021) & (US$ Million) Table 68. Astellas Pharma, Inc. Recent Development Table 69. Eli Lilly and Co. Company Details Table 70. Eli Lilly and Co. Business Overview Table 71. Eli Lilly and Co. Janus Kinase (JAK) Inhibitors Product Table 72. Eli Lilly and Co. Revenue in Janus Kinase (JAK) Inhibitors Business (2016-2021) & (US$ Million) Table 73. Eli Lilly and Co. Recent Development Table 74. Incyte Corp. Company Details Table 75. Incyte Corp. Business Overview Table 76. Incyte Corp. Janus Kinase (JAK) Inhibitors Product Table 77. Incyte Corp. Revenue in Janus Kinase (JAK) Inhibitors Business (2016-2021) & (US$ Million) Table 78. Incyte Corp. Recent Development Table 79. Novartis AG Company Details Table 80. Novartis AG Business Overview Table 81. Novartis AG Janus Kinase (JAK) Inhibitors Product Table 82. Novartis AG Revenue in Janus Kinase (JAK) Inhibitors Business (2016-2021) & (US$ Million) Table 83. Novartis AG Recent Development Table 84. Pfizer Inc. Company Details Table 85. Pfizer Inc. Business Overview Table 86. Pfizer Inc. Janus Kinase (JAK) Inhibitors Product Table 87. Pfizer Inc. Revenue in Janus Kinase (JAK) Inhibitors Business (2016-2021) & (US$ Million) Table 88. Pfizer Inc. Recent Development Table 89. Research Programs/Design for This Report Table 90. Key Data Information from Secondary Sources Table 91. Key Data Information from Primary Sources List of Figures Figure 1. Global Janus Kinase (JAK) Inhibitors Market Share by Type: 2020 VS 2027 Figure 2. Ruxolitinib Features Figure 3. Tofacitinib Features Figure 4. Oclacitinib Features Figure 5. Baricitinib Features Figure 6. Peficitinib Features Figure 7. Global Janus Kinase (JAK) Inhibitors Market Share by Application: 2020 VS 2027 Figure 8. Autoimmune Disorders Case Studies Figure 9. Oncology Case Studies Figure 10. Janus Kinase (JAK) Inhibitors Report Years Considered Figure 11. Global Janus Kinase (JAK) Inhibitors Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 12. Global Janus Kinase (JAK) Inhibitors Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Janus Kinase (JAK) Inhibitors Market Share by Regions: 2020 VS 2027 Figure 14. Global Janus Kinase (JAK) Inhibitors Market Share by Regions (2022-2027) Figure 15. Global Janus Kinase (JAK) Inhibitors Market Share by Players in 2020 Figure 16. Global Top Janus Kinase (JAK) Inhibitors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Janus Kinase (JAK) Inhibitors as of 2020 Figure 17. The Top 10 and 5 Players Market Share by Janus Kinase (JAK) Inhibitors Revenue in 2020 Figure 18. Global Janus Kinase (JAK) Inhibitors Revenue Market Share by Type (2016-2021) Figure 19. Global Janus Kinase (JAK) Inhibitors Revenue Market Share by Type (2022-2027) Figure 20. North America Janus Kinase (JAK) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million) Figure 21. North America Janus Kinase (JAK) Inhibitors Market Share by Type (2016-2027) Figure 22. North America Janus Kinase (JAK) Inhibitors Market Share by Application (2016-2027) Figure 23. North America Janus Kinase (JAK) Inhibitors Market Share by Country (2016-2027) Figure 24. United States Janus Kinase (JAK) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Canada Janus Kinase (JAK) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Janus Kinase (JAK) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Janus Kinase (JAK) Inhibitors Market Share by Type (2016-2027) Figure 28. Europe Janus Kinase (JAK) Inhibitors Market Share by Application (2016-2027) Figure 29. Europe Janus Kinase (JAK) Inhibitors Market Share by Country (2016-2027) Figure 30. Germany Janus Kinase (JAK) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. France Janus Kinase (JAK) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. U.K. Janus Kinase (JAK) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Italy Janus Kinase (JAK) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Russia Janus Kinase (JAK) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Nordic Janus Kinase (JAK) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Janus Kinase (JAK) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Janus Kinase (JAK) Inhibitors Market Share by Type (2016-2027) Figure 38. Asia-Pacific Janus Kinase (JAK) Inhibitors Market Share by Application (2016-2027) Figure 39. Asia-Pacific Janus Kinase (JAK) Inhibitors Market Share by Region (2016-2027) Figure 40. China Janus Kinase (JAK) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Japan Janus Kinase (JAK) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. South Korea Janus Kinase (JAK) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Southeast Asia Janus Kinase (JAK) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. India Janus Kinase (JAK) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Australia Janus Kinase (JAK) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Janus Kinase (JAK) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Janus Kinase (JAK) Inhibitors Market Share by Type (2016-2027) Figure 48. Latin America Janus Kinase (JAK) Inhibitors Market Share by Application (2016-2027) Figure 49. Latin America Janus Kinase (JAK) Inhibitors Market Share by Country (2016-2027) Figure 50. Mexico Janus Kinase (JAK) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Brazil Janus Kinase (JAK) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Janus Kinase (JAK) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Janus Kinase (JAK) Inhibitors Market Share by Type (2016-2027) Figure 54. Middle East & Africa Janus Kinase (JAK) Inhibitors Market Share by Application (2016-2027) Figure 55. Middle East & Africa Janus Kinase (JAK) Inhibitors Market Share by Country (2016-2027) Figure 56. Turkey Janus Kinase (JAK) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Saudi Arabia Janus Kinase (JAK) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. UAE Janus Kinase (JAK) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Astellas Pharma, Inc. Revenue Growth Rate in Janus Kinase (JAK) Inhibitors Business (2016-2021) Figure 60. Eli Lilly and Co. Revenue Growth Rate in Janus Kinase (JAK) Inhibitors Business (2016-2021) Figure 61. Incyte Corp. Revenue Growth Rate in Janus Kinase (JAK) Inhibitors Business (2016-2021) Figure 62. Novartis AG Revenue Growth Rate in Janus Kinase (JAK) Inhibitors Business (2016-2021) Figure 63. Pfizer Inc. Revenue Growth Rate in Janus Kinase (JAK) Inhibitors Business (2016-2021) Figure 64. Bottom-up and Top-down Approaches for This Report Figure 65. Data Triangulation Figure 66. Key Executives Interviewed

Astellas Pharma, Inc. Eli Lilly and Co. Incyte Corp. Novartis AG Pfizer Inc.